Abstract
The vertiginous expansion of knowledge about endocrinology brings some caveats to the clinical practice. For instance, differentiated thyroid cancer, which was a relatively uncommon neoplasia 40 years ago1, has been increasing more than any other type of cancer in the last decade2. In fact, it became the most common neoplasia in women of certain countries3. However, despite this impressive increase in incidence, differentiated thyroid cancer mortality rates remain like 40 years ago1. This article is protected by copyright. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
